Mitsuhiro Hayashi - Concepedia

Author

Mitsuhiro Hayashi

Kumamoto University ORCID

Also Known As

M Hayashi, M. Hayashi, MITSUHIRO HAYASHI, Mitsuhiro HAYASHI, Mitsuhiro Hayashi, Mitsuhiro. Hayashi

139

Publications

Citations

H-Index

Concepts

All Affiliations

Kumamoto University Kumamoto University Hospital Dokkyo Medical University Kumamoto City Hospital Mitsubishi Group (Japan)

About

Mitsuhiro Hayashi is an author at Kumamoto University specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	996
2	Health Sciences	5	5	288
3	Business	3	3	92
4	Education	1	1	26
5	Engineering	1	1	12

Mitsuhiro Hayashi

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer Reiki Nishimura, Tomofumi Osako, Yasuhiro Okumura, Experimental and Therapeutic Medicine Surgical OncologyBreast OncologyCancer ManagementPathologyGynecology	2010	178
Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis Reiki Nishimura, Tomofumi Osako, Yasuhiro Okumura, Breast Cancer Breast OncologyMedicinePathologyPrimary Breast CancerBreast Cancer	2009	134
Evaluation of Tumor Stiffness by Elastography Is Predictive for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer Mitsuhiro Hayashi, Yutaka Yamamoto, Mutsuko Ibusuki, Annals of Surgical Oncology Surgical OncologyBreast OncologyNeoadjuvant ChemotherapyMedicineElastography	2012	111
The relationship between FDG uptake in PET scans and biological behavior in breast cancer Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Breast Cancer Positron Emission TomographyPet ScansMedical ImagingOncologic ImagingMedicine	2007	97
CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast Tsengelmaa Jamiyan, Hajime Kuroda, Rin Yamaguchi, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin	2020	88
Clinical significance of CYLD downregulation in breast cancer Mitsuhiro Hayashi, Hirofumi Jono, Satoru Shinriki, Breast Cancer Research and Treatment Breast OncologyMedicinePathologyBreast CancerOncology	2014	75
A novel method for evaluating antibody-dependent cell-mediated cytotoxicity by flowcytometry using cryopreserved human peripheral blood mononuclear cells Makiko Yamashita, Shigehisa Kitano, Hiroaki Aikawa, Scientific Reports	2016	62
Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts Masamichi Takahashi, Shunichiro Miki, Kenji Fujimoto, Cancer Science	2019	61
Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes? Aiko Sueta, Yutaka Yamamoto, Mitsuhiro Hayashi, Surgery Pretherapeutic Ki67Breast OncologyMedicinePathologyBreast Cancer	2014	56
Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer Mai Tomiguchi, Yutaka Yamamoto, Mutsuko Yamamoto‐Ibusuki, Cancer Science	2016	51

Page 1